Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV−ve Oropharynx cancer? A population-based study

Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV−ve Oropharynx cancer? A population-based study

British Journal of Cancer advance online publication, August 22 2017. doi:10.1038/bjc.2017.275

Authors: Stephen F Hall, Fei-Fei Liu, Brian O'Sullivan, Willa Shi, Susan Rohland, Rebecca Griffiths & Patti Groome

http://ift.tt/2vW9IKQ